Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

[1]  Erin L. Schenk,et al.  Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing , 2020, Cell.

[2]  Nayoung K. D. Kim,et al.  Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma , 2020, Nature Communications.

[3]  Gordon F Heidkamp,et al.  The ontogenetic path of human dendritic cells. , 2020, Molecular immunology.

[4]  Huanming Yang,et al.  An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates. , 2020, Cancer cell.

[5]  Gavin D. Meredith,et al.  Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC. , 2019, JCI insight.

[6]  R. Bourgon,et al.  Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy. , 2019, Cancer discovery.

[7]  W. Seeger,et al.  Epithelial cell plasticity defines heterogeneity in lung cancer. , 2019, Cellular signalling.

[8]  S. Loi,et al.  Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade , 2019, Clinical Cancer Research.

[9]  Jonathan M. Hernandez,et al.  Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer. , 2019, Cancer cell.

[10]  Martin L. Miller,et al.  UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma , 2019, Cell.

[11]  Virginia Savova,et al.  Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. , 2019, Immunity.

[12]  Ying Cheng,et al.  Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients , 2019, Nature Communications.

[13]  S. Patnaik,et al.  Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients , 2019, Annals of Surgical Oncology.

[14]  E. Felip,et al.  Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors , 2019, Cancer Immunology, Immunotherapy.

[15]  Kristin D. Alfaro,et al.  The molecular landscape of glioma in patients with Neurofibromatosis 1 , 2018, Nature Medicine.

[16]  Atul J. Butte,et al.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.

[17]  Kerstin B. Meyer,et al.  Single-cell reconstruction of the early maternal–fetal interface in humans , 2018, Nature.

[18]  Chris J. Stubben,et al.  The Lineage‐Defining Transcription Factors SOX2 and NKX2–1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment , 2018, Immunity.

[19]  P. Carmeliet,et al.  Phenotype molding of stromal cells in the lung tumor microenvironment , 2018, Nature Medicine.

[20]  Helge G. Roider,et al.  Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing , 2018, Nature Medicine.

[21]  S. Novello,et al.  Pembrolizumab plus Chemotherapy in Metastatic Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.

[22]  R. Weinberg,et al.  Understanding the tumor immune microenvironment (TIME) for effective therapy , 2018, Nature Medicine.

[23]  P. Wei,et al.  The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis. , 2018, Pathology, research and practice.

[24]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[25]  James Hicks,et al.  Unravelling biology and shifting paradigms in cancer with single-cell sequencing , 2017, Nature Reviews Cancer.

[26]  Russell B. Fletcher,et al.  Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics , 2017, BMC Genomics.

[27]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[28]  A. M. Houghton,et al.  Neutrophils dominate the immune cell composition in non-small cell lung cancer , 2017, Nature Communications.

[29]  Charles H. Yoon,et al.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq , 2016, Science.

[30]  Sara Omenetti,et al.  The Treg/Th17 Axis: A Dynamic Balance Regulated by the Gut Microbiome , 2015, Front. Immunol..

[31]  D. Nguyen,et al.  Lineage factors and differentiation states in lung cancer progression , 2015, Oncogene.

[32]  R. Salgia.  Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors , 2014, Cancer medicine.

[33]  Cole Trapnell,et al.  Pseudo-temporal ordering of individual cells reveals dynamics and regulators of cell fate decisions , 2014, Nature Biotechnology.

[34]  A. Luster,et al.  CXCR3 in T cell function. , 2011, Experimental cell research.

[35]  L. Cosmi,et al.  Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor , 2008, The Journal of experimental medicine.

[36]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[37]  S. Zheng.  Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive? , 2013, American journal of clinical and experimental immunology.

[38]  A. Ostman.  The tumor microenvironment controls drug sensitivity. , 2012, Nature medicine.

[39]  P. Howarth,et al.  Preliminary study of the cellular characteristics of primary bronchial fibroblasts in patients with asthma: expression of alpha-smooth muscle actin, fibronectin containing extra type III domain A, and smoothelin. , 2012, Journal of investigational allergology & clinical immunology.